These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36879304)

  • 1. "Sometimes you have to take the person and show them how": adapting behavioral activation for peer recovery specialist-delivery to improve methadone treatment retention.
    Kleinman MB; Anvari MS; Bradley VD; Felton JW; Belcher AM; Seitz-Brown CJ; Greenblatt AD; Dean D; Bennett M; Magidson JF
    Subst Abuse Treat Prev Policy; 2023 Mar; 18(1):15. PubMed ID: 36879304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "You rise up and then you start pulling people up with you": Patient experiences with a peer-delivered behavioral activation intervention to support methadone treatment.
    Kleinman MB; Hines AC; Anvari MS; Bradley VD; Shields A; Dean D; Abidogun TM; Jack HE; Magidson JF
    Int J Drug Policy; 2023 Dec; 122():104234. PubMed ID: 37866292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peer recovery specialist-delivered, behavioral activation intervention to improve retention in methadone treatment: Results from an open-label, Type 1 hybrid effectiveness-implementation pilot trial.
    Magidson JF; Kleinman MB; Bradley V; Anvari MS; Abidogun TM; Belcher AM; Greenblatt AD; Dean D; Hines A; Seitz-Brown CJ; Wagner M; Bennett M; Felton JW
    Int J Drug Policy; 2022 Oct; 108():103813. PubMed ID: 35932644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adapting a peer recovery coach-delivered behavioral activation intervention for problematic substance use in a medically underserved community in Baltimore City.
    Satinsky EN; Doran K; Felton JW; Kleinman M; Dean D; Magidson JF
    PLoS One; 2020; 15(1):e0228084. PubMed ID: 32004328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "In their mind, they always felt less than": The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention.
    Anvari MS; Kleinman MB; Massey EC; Bradley VD; Felton JW; Belcher AM; Magidson JF
    J Subst Abuse Treat; 2022 Jul; 138():108721. PubMed ID: 35067397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial challenges affecting patient-defined medication for opioid use disorder treatment outcomes in a low-income, underserved population: Application of the social-ecological framework.
    Kleinman MB; Anvari MS; Seitz-Brown CJ; Bradley VD; Tralka H; Felton JW; Belcher AM; Greenblatt AD; Magidson JF
    J Subst Use Addict Treat; 2023 Jun; 149():209046. PubMed ID: 37061189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose: A Randomized Clinical Trial.
    Beaudoin FL; Jacka BP; Li Y; Samuels EA; Hallowell BD; Peachey AM; Newman RA; Daly MM; Langdon KJ; Marshall BDL
    JAMA Netw Open; 2022 Aug; 5(8):e2225582. PubMed ID: 35943744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in substance use stigma following a peer-recovery specialist behavioral activation intervention.
    Kleinman MB; Anvari MS; Felton JW; Bradley VD; Belcher AM; Abidogun TM; Hines AC; Dean D; Greenblatt AD; Wagner M; Earnshaw VA; Magidson JF
    Int J Drug Policy; 2024 Aug; 130():104511. PubMed ID: 39003894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
    Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
    Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations.
    Husain JM; Cromartie D; Fitzelle-Jones E; Brochier A; Borba CPC; Montalvo C
    J Subst Abuse Treat; 2023 Jan; 144():108918. PubMed ID: 36403456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.
    Wu LT; John WS; Morse ED; Adkins S; Pippin J; Brooner RK; Schwartz RP
    Addiction; 2022 Feb; 117(2):444-456. PubMed ID: 34286886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying a mutual capacity building model to inform peer provider programs in South Africa and the United States: A combined qualitative analysis.
    Jack HE; Anvari MS; Abidogun TM; Ochieng YA; Ciya N; Ndamase S; Rose AL; Kleinman MB; Myers B; Magidson JF
    Int J Drug Policy; 2023 Oct; 120():104144. PubMed ID: 37567035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder.
    Ober AJ; Murray-Krezan C; Page K; Friedmann PD; Chan Osilla K; Ryzewicz S; Huerta S; Mazer MW; Leamon I; Messineo G; Watkins KE; Nuckols T; Danovitch I
    Addict Sci Clin Pract; 2022 Jul; 17(1):39. PubMed ID: 35902888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland's drug and alcohol services.
    Moran L; Keenan E; Elmusharaf K
    BMC Health Serv Res; 2018 Nov; 18(1):911. PubMed ID: 30497467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder.
    Randall-Kosich O; Andraka-Christou B; Totaram R; Alamo J; Nadig M
    J Addict Med; 2020; 14(4):e44-e52. PubMed ID: 31651562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of an AIDS prevention program for methadone patients.
    Magura S; Siddiqi Q; Shapiro J; Grossman JI; Lipton DS; Marion IJ; Weisenfeld L; Amann KR; Koger J
    Int J Addict; 1991 Jun; 26(6):629-55. PubMed ID: 1757169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing psychiatric comorbidity within versus outside of methadone treatment settings: a randomized and controlled evaluation.
    Brooner RK; Kidorf MS; King VL; Peirce J; Neufeld K; Stoller K; Kolodner K
    Addiction; 2013 Nov; 108(11):1942-51. PubMed ID: 23734943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities.
    Pasman E; Kollin R; Broman M; Lee G; Agius E; Lister JJ; Brown S; Resko SM
    Addict Sci Clin Pract; 2022 Jul; 17(1):35. PubMed ID: 35841076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proactive, Recovery-Oriented Treatment Navigation to Engage Racially Diverse Veterans in Mental Healthcare (PARTNER-MH), a Peer-Led Patient Navigation Intervention for Racially and Ethnically Minoritized Veterans in Veterans Health Administration Mental Health Services: Protocol for a Mixed Methods Randomized Controlled Feasibility Study.
    Eliacin J; Burgess DJ; Rollins AL; Patterson S; Damush T; Bair MJ; Salyers MP; Spoont M; Slaven JE; O'Connor C; Walker K; Zou DS; Austin E; Akins J; Miller J; Chinman M; Matthias MS
    JMIR Res Protoc; 2022 Sep; 11(9):e37712. PubMed ID: 36066967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.